Jürgen Steffgen

870 total citations
25 papers, 639 citations indexed

About

Jürgen Steffgen is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Jürgen Steffgen has authored 25 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Immunology. Recurrent topics in Jürgen Steffgen's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Ion Transport and Channel Regulation (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jürgen Steffgen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Ion Transport and Channel Regulation (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jürgen Steffgen collaborates with scholars based in Germany, United States and France. Jürgen Steffgen's co-authors include Gerhard Burckhardt, Birgitta C. Burckhardt, Gerhard A. Müller, Sudha Visvanathan, Jay S. Fine, Meera Ramanujam, Karel Geboes, Thomas Knittel, Geert D’Haens and Jean‐Frédéric Colombel and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jürgen Steffgen

25 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jürgen Steffgen Germany 14 228 146 145 127 112 25 639
Tian Du China 15 671 2.9× 181 1.2× 241 1.7× 94 0.7× 49 0.4× 39 1.2k
Teruaki Kimura Japan 16 321 1.4× 375 2.6× 98 0.7× 228 1.8× 267 2.4× 27 974
Stacy Carl-McGrath Germany 15 417 1.8× 96 0.7× 376 2.6× 46 0.4× 39 0.3× 17 926
Naoaki Akisawa Japan 14 341 1.5× 121 0.8× 103 0.7× 592 4.7× 243 2.2× 21 1.0k
Carole Ferraro‐Peyret France 13 300 1.3× 118 0.8× 113 0.8× 90 0.7× 15 0.1× 28 673
Min Feng China 18 251 1.1× 177 1.2× 240 1.7× 138 1.1× 71 0.6× 31 803
Yu Geng China 16 386 1.7× 103 0.7× 113 0.8× 107 0.8× 33 0.3× 20 684
Serena De Matteis Italy 13 282 1.2× 119 0.8× 162 1.1× 104 0.8× 115 1.0× 34 658
S Nishi Japan 14 374 1.6× 354 2.4× 92 0.6× 77 0.6× 42 0.4× 36 976

Countries citing papers authored by Jürgen Steffgen

Since Specialization
Citations

This map shows the geographic impact of Jürgen Steffgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Steffgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Steffgen more than expected).

Fields of papers citing papers by Jürgen Steffgen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Steffgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Steffgen. The network helps show where Jürgen Steffgen may publish in the future.

Co-authorship network of co-authors of Jürgen Steffgen

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Steffgen. A scholar is included among the top collaborators of Jürgen Steffgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Steffgen. Jürgen Steffgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jayne, David, Jürgen Steffgen, Juanita Romero‐Díaz, et al.. (2023). Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti‐CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Trial. Arthritis & Rheumatology. 75(11). 1983–1993. 13 indexed citations
3.
Ramanujam, Meera, Jürgen Steffgen, Sudha Visvanathan, et al.. (2020). Phoenix from the flames: Rediscovering the role of the CD40–CD40L pathway in systemic lupus erythematosus and lupus nephritis. Autoimmunity Reviews. 19(11). 102668–102668. 52 indexed citations
4.
Tsuda, Yasuhiro, Christine Grimaldi, Fenglei Huang, et al.. (2020). Safety, pharmacokinetics and pharmacodynamics of BI 655064 in phase 1 clinical trials in healthy Chinese and Japanese subjects. British Journal of Clinical Pharmacology. 87(4). 2000–2013. 4 indexed citations
5.
Litzenburger, Tobias, Jürgen Steffgen, Fabian Müller, et al.. (2020). Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers. British Journal of Clinical Pharmacology. 87(4). 1824–1838. 4 indexed citations
6.
Visvanathan, Sudha, Ulf Müller‐Ladner, Meera Ramanujam, et al.. (2019). Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. Annals of the Rheumatic Diseases. 78(6). 754–760. 44 indexed citations
7.
Litzenburger, Tobias, Fabian Müller, Armin Schultz, et al.. (2019). 32 Safety, pharmacokinetics and pharmacodynamics of BI 705564, a covalent inhibitor of brutons tyrosine kinase in phase 1 clinical trials in healthy volunteers. Abstracts. A23.3–A24. 1 indexed citations
8.
Wagner, Frank, Andreas Hüser, David Joseph, et al.. (2017). Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases. European Journal of Clinical Pharmacology. 74(2). 161–169. 30 indexed citations
9.
Hagos, Yohannes, et al.. (2006). Functional roles of cationic amino acid residues in the sodium-dicarboxylate cotransporter 3 (NaDC-3) from winter flounder. American Journal of Physiology-Renal Physiology. 291(6). F1224–F1231. 7 indexed citations
10.
Schreiber, Stefan, Brian G. Feagan, Geert D’Haens, et al.. (2006). Oral p38 Mitogen-Activated Protein Kinase Inhibition With BIRB 796 for Active Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology. 4(3). 325–334. 146 indexed citations
11.
Asif, Abdul R., Jürgen Steffgen, R. Willi Grunewald, et al.. (2004). Presence of organic anion transporters 3 (OAT3) and 4 (OAT4) in human adrenocortical cells. Pflügers Archiv - European Journal of Physiology. 450(2). 88–95. 39 indexed citations
12.
Hagos, Yohannes, Birgitta C. Burckhardt, Christian Mathys, et al.. (2004). Regulation of sodium-dicarboxylate cotransporter-3 from winter flounder kidney by protein kinase C. American Journal of Physiology-Renal Physiology. 286(1). F86–F93. 17 indexed citations
13.
Burckhardt, Birgitta C., et al.. (2004). Interactions of Benzylpenicillin and Non-steroidal Anti-inflammatory Drugs with the Sodium-dependent Dicarboxylate Transporter NaDC-3. Cellular Physiology and Biochemistry. 14(4-6). 415–424. 12 indexed citations
14.
Hentschel, Hartmut, et al.. (2003). Basolateral localization of flounder Na+-dicarboxylate cotransporter (fNaDC-3) in the kidney of Pleuronectes americanus. Pflügers Archiv - European Journal of Physiology. 446(5). 578–584. 11 indexed citations
15.
Kobold, Dominik, Fabio Piscaglia, Christoph Eisenbach, et al.. (2002). Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts. Journal of Hepatology. 36(5). 607–613. 78 indexed citations
16.
Burckhardt, Birgitta C., et al.. (2000). Potential-dependent steady-state kinetics of a dicarboxylate transporter cloned from winter flounder kidney. Pflügers Archiv - European Journal of Physiology. 441(2-3). 323–330. 7 indexed citations
17.
Steffgen, Jürgen, Birgitta C. Burckhardt, Christoph Langenberg, et al.. (1999). Expression Cloning and Characterization of a Novel Sodium-Dicarboxylate Cotransporter from Winter Flounder Kidney. Journal of Biological Chemistry. 274(29). 20191–20196. 32 indexed citations
18.
Steffgen, Jürgen, Saskia Rohrbach, Hubertus Jarry, et al.. (1999). Demonstration of a Probenecid-Inhibitable Anion Exchanger Involved in the Release of Cortisol and cAMP and in the Uptake of <i>p</i>-Aminohippurate in Bovine Adrenocortical Cells. Cellular Physiology and Biochemistry. 9(2). 72–80. 11 indexed citations
19.
Grupp, Clemens, Jürgen Steffgen, Sigrid A. Langhans, et al.. (1998). Highly Specific Separation of Heterogeneous Cell Populations by Lectin-Coated Beads: Application for the Isolation of Inner Medullary Collecting Duct Cells. Nephron Experimental Nephrology. 6(6). 542–550. 14 indexed citations
20.
Steffgen, Jürgen, et al.. (1993). Characterization of p-aminohippurate transport from rat kidney which is expressed after injection of size-selected mRNA into oocytes of Xenopus laevis. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1149(1). 145–150. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026